Re-thinking BioTED, a Technical Innovation Portfolio for Biologics

3/9/2020 13:50 - 14:25

BioTED (Biologics Technology Evaluation and Development), is the global technical innovation portfolio of Roche Pharmaceutical Technical Development Biologics, encompassing drug substance, analytics and drug product innovation projects selected after a call for proposals. Stimulated by the urge to deliver better products faster and cheaper to our patients, we have recently been looking into opportunities to transform BioTED to deliver more on strategic innovation. The presentation will illustrate the main steps of the transformation journey that led to a new innovation model for BioTED.

  • CMC Innovation in formulation/manufacturing process and analytical development
  • Innovation models
  • Teamwork and collaboration
  • Design Thinking

Please note that this will be a remote presentation

Gregoire Schwach, E2E Home Leader Ocular and Drug Delivery, Roche

Back to programme